Publications

1. Piñeros M, Saraiya M, Baussano I, Bonjour M, Chao A, Bray F (2021). The role and utility of population-based cancer registries in cervical cancer surveillance and control. Prev Med. 144:106237. https://doi.org/10.1016/j.ypmed.2020.106237 PMID:33678223
2. Ryzhov A, Corbex M, Piñeros M, Barchuk A, Andreasyan D, Djanklich S, et al. (2021). Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study. Lancet Oncol. 22(3):361–9. https://doi.org/10.1016/S1470-2045(20)30674-4 PMID:33556324
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. caac.21660. https://doi.org/10.3322/caac.21660 PMID:33538338
4. Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schüz J, et al.; IICC-3 contributors (2021). Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 9(3):144–52. https://doi.org/10.1016/S2213-8587(20)30401-0 PMID:33482107
5. Kulhánová I, Forman D, Vignat J, Espina C, Brenner H, Storm HH, et al. (2020). Tobacco-related cancers in Europe: the scale of the epidemic in 2018. Eur J Cancer. 139:27–36. https://doi.org/10.1016/j.ejca.2020.07.024 PMID:32957011
6. Miranda-Filho A, Bray F, Charvat H, Rajaraman S, Soerjomataram I (2020). The world cancer patient population (WCPP): an updated standard for international comparisons of population-based survival. Cancer Epidemiol. 69:101802. https://doi.org/10.1016/j.canep.2020.101802 PMID:32942139
7. Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, et al. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 70(2):234–42. https://doi.org/10.1136/gutjnl-2020-321089 PMID:32554620
8. Piñeros M, Mery L, Soerjomataram I, Bray F, Steliarova-Foucher E (2021). Scaling up the surveillance of childhood cancer: a global roadmap. J Natl Cancer Inst. 113(1):9–15. https://doi.org/10.1093/jnci/djaa069 PMID:32433739
9. Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I (2020). Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 69(5):823–9. https://doi.org/10.1136/gutjnl-2019-320234 PMID:32001553
10. Znaor A, Skakkebaek NE, Rajpert-De Meyts E, Laversanne M, Kuliš T, Gurney J, et al. (2020). Testicular cancer incidence predictions in Europe 2010-2035: a rising burden despite population ageing. Int J Cancer. 147(3):820–8. https://doi.org/10.1002/ijc.32810 PMID:31773729
11. Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, et al. (2020). The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer. 146(3):749–58. https://doi.org/10.1002/ijc.32322 PMID:30968402
12. Steliarova-Foucher E (2019). How can global incidence estimates support childhood cancer control? Lancet Oncol. 20(4):460–1. https://doi.org/10.1016/S1470-2045(19)30039-7 PMID:30824205
13. Piñeros M, Parkin DM, Ward K, Chokunonga E, Ervik M, Farrugia H, et al. (2019). Essential TNM: a registry tool to reduce gaps in cancer staging information. Lancet Oncol. 20(2):e103–11. https://doi.org/10.1016/S1470-2045(18)30897-0 PMID:30712797
14. Vaccarella S, Lortet-Tieulent J, Saracci R, Fidler MM, Conway DI, Vilahur N, et al. (2018). Reducing social inequalities in cancer: setting priorities for research. CA Cancer J Clin. 68(5):324–6. https://doi.org/10.3322/caac.21463 PMID:30152865
15. Meheus F, Atun R, Ilbawi A (2019). The role of health systems in addressing inequalities in access to cancer control. In: Vaccarella S, Lortet-Tieulent J, Saracci R, Conway DI, Straif K, Wild CP, editors. Reducing social inequalities in cancer: evidence and priorities for research (IARC Scientific Publications, No. 168). Lyon, France: International Agency for Research on Cancer. Available from: https://publications.iarc.fr/580.
16. Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. (2019). Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 144(12):2992–3000. https://doi.org/10.1002/ijc.32055 PMID:30536395
17. Soerjomataram I, Shield K, Marant-Micallef C, Vignat J, Hill C, Rogel A, et al. (2018). Cancers related to lifestyle and environmental factors in France in 2015. Eur J Cancer. 105:103–13. https://doi.org/10.1016/j.ejca.2018.09.009 PMID:30445359
18. Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancela M, et al. (2018). Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): a population-based comparison. Cancer Epidemiol. 53:27–34. https://doi.org/10.1016/j.canep.2017.12.013 PMID:29353153
19. Cao B, Bray F, Beltrán-Sánchez H, Ginsburg O, Soneji S, Soerjomataram I (2017). Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010. BMJ. 357:j2765. https://doi.org/10.1136/bmj.j2765 PMID:28637656
20. Piñeros M, Znaor A, Mery L, Bray F (2017). A global cancer surveillance framework within noncommunicable disease surveillance: making the case for population-based cancer registries. Epidemiol Rev. 39(1):161–9. https://doi.org/10.1093/epirev/mxx003 PMID:28472440